Adamas Pharmaceuticals Inc (ADMS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1900 POWELL ST., SUITE 1000 EMERYVILLE, CA 94608

Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

Data as of 2021-07-19 09:18:08 -0400
Market Cap230.673 Million Shares Outstanding45.408 Million Avg 30-day Volume239.516 Thousand
P/E Ratio-4.32555 Dividend Yield EPS-1.77
Price/Sales2.91 Debt to Equity28.51 EBITDA-39.828 Million
Price to Book Value38.85 Forward PE25.4 Enterprise Value235.581 Million
Total Cash124.831 Million Current Debt29.176 Million Gross Profit77.44 Million
BETA0.62416 52-week High/Low9.15 / 2.43 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -12.8409
Data provided by IEX Cloud
View SEC Filings from ADMS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.06%) 0 (0.0%)
Funds Holding: 71 64 10.94% 33 (1.94%) 25 (1.45%) 32.0%
13F shares: 28.879 Million 14.274 Million 102.33% 17.36 Million 10.409 Million 66.77%
% Ownership 94.4734 50.0467 88.77% 56.7909 36.4978 55.6%
New Positions: 18 10 80.0% 13 3 333.33%
Increased Positions 26 21 23.81% 14 11 27.27%
Closed Positions 11 9 22.22% 5 1 400.0%
Reduced Positions 17 17 0.0% 4 7 -42.86%
Total Calls 169.488 Thousand 13.112 Thousand 1192.62% 34.7 Thousand 12.8 Thousand 171.09%
Total Puts 141.127 Thousand 25.6 Thousand 451.28% 39.8 Thousand 15.4 Thousand 158.44%
PUT/CALL Ratio 0.83 1.95 -57.44% 1.15 1.2 -4.17%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ADMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADMS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

8.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHREEDHAR VIJAY CHIEF COMMERCIAL OFFICER

  • Officer
165,735 2021-06-21 4

DEMSKI MARTHA J

  • Director
21,000 2021-06-07 2

ERICSON WILLIAM W.

  • Director
  • 10% Owner
4,639,796 2021-06-02 1

MACPHEE JOHN A

  • Director
212,000 2021-06-02 2

MAHONEY DAVID L

  • Director
127,781 2021-06-02 2

BIGHAM MICHAEL

  • Director
20,000 2021-06-02 1

DIER MARDI

  • Director
20,000 2021-06-02 1

RICHO ANNA

  • Director
35,000 2021-06-02 3

PAPAPETROPOULOS SPYRIDON

  • Director
30,975 2021-06-02 4

PRENTISS CHRISTOPHER B CHIEF FINANCIAL OFFICER

  • Officer
145,017 2021-03-22 5

MCFARLANE NEIL F. CHIEF EXECUTIVE OFFICER

  • Officer
525,000 2021-03-02 1

LIEBERBURG IVAN M

  • Director
69,000 2020-06-03 0

MERRIWEATHER ALFRED G CHIEF FINANCIAL OFFICER

  • Officer
48,019 2019-09-20 0

RHODES JENNIFER J CBO, GC & COMPLIANCE OFFICER

  • Officer
63,114 2019-06-20 0

WENT GREGORY T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
431,783 2019-04-08 0

PATNI RAJIV CHIEF MEDICAL OFFICER

  • Officer
49,141 2019-04-08 0

KING RICHARD CHIEF OPERATING OFFICER

  • Officer
48,856 2018-06-21 0

GREAT POINT PARTNERS LLC

JAY JEFFREY R

KROIN DAVID

  • 10% Owner
No longer subject to file 2017-06-19 0

BOOTH RICHARD H

  • Director
0 2017-06-01 0

DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

  • Officer
14,284 2017-03-21 0

MDV IX LP

SEVENTH MDV PARTNERS, L.L.C.

NINTH MDV PARTNERS, L.L.C.

FEIBER JONATHAN D

SCHOENDORF NANCY J

MDV ENF VII (A), L.P.

MDV ENF VII (B), L.P.

MDV VII LEADERS' FUND, L.P.

MDV VII LP

  • 10% Owner
4,619,796 2016-09-14 0

MCCLURE NATALIE SVP, PRODUCT DEVELOPMENT

  • Officer
8,340 2016-04-18 0

LEWIS SARA GROOTWASSINK

  • Director
0 2015-05-14 0

AERIS CAPITAL EQUITY INVESTMENTS, L.P.

  • 10% Owner
1,662,128 2015-03-13 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
0 2015-02-25 0

SHIN GRACE GENERAL COUNSEL

  • Officer
0 2014-12-01 0

DAG VENTURES MANAGEMENT III, LLC

DAG VENTURES III-QP LP

DAG VENTURES III, L.P.

DAG VENTURES GP FUND III, LLC

CADEDDU JOHN J.

GOODRICH R. THOMAS

  • 10% Owner
1,660,229 2014-04-15 0

RIMAC ANTHONY M CHIEF FINANCIAL OFFICER

  • Officer
0 2014-04-09 0

MDV IX LP

NINTH MDV PARTNERS, L.L.C.

FEIBER JONATHAN D

MDV VII LP

SEVENTH MDV PARTNERS, L.L.C.

SCHOENDORF NANCY J

  • 10% Owner
2,742,702 2014-04-09 0

COFFEE MICHAEL DENIS SENIOR VP, STRATEGY & PLANNING

  • Officer
0 2014-04-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SHREEDHAR VIJAY - Officer CHIEF COMMERCIAL OFFICER

2021-06-23 16:09:48 -0400 2021-06-21 S 6,200 $5.16 d 165,735 direct -2.243 4.2991 4.2991 6 -3.9252 4

DEMSKI MARTHA J - Director

2021-06-08 17:32:33 -0400 2021-06-07 S 2,000 $5.17 d 8,000 direct yes 5.7495 6.7762 3.0801 15.1951 19 0.0 1

ERICSON WILLIAM W. - Director - > 10% Owner

2021-06-04 16:14:14 -0400 2021-06-02 A 5,000 a 10,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

MAHONEY DAVID L - Director

2021-06-04 16:15:41 -0400 2021-06-02 A 5,000 a 115,153 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

RICHO ANNA - Director

2021-06-04 16:17:14 -0400 2021-06-02 A 10,000 a 10,000 direct

PAPAPETROPOULOS SPYRIDON - Director

2021-06-04 16:16:19 -0400 2021-06-02 A 5,000 a 20,975 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

DEMSKI MARTHA J - Director

2021-06-04 16:13:24 -0400 2021-06-02 A 10,000 a 10,000 direct

DIER MARDI - Director

2021-06-04 16:13:53 -0400 2021-06-02 A 5,000 a 10,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

MACPHEE JOHN A - Director

2021-06-04 16:15:05 -0400 2021-06-02 A 10,000 a 10,000 direct

RICHO ANNA - Director

2021-06-04 16:17:14 -0400 2021-06-02 A 5,000 a 25,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

BIGHAM MICHAEL - Director

2021-06-04 16:12:57 -0400 2021-06-02 A 10,000 a 10,000 direct

DEMSKI MARTHA J - Director

2021-06-04 16:13:24 -0400 2021-06-02 A 5,000 a 10,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

ERICSON WILLIAM W. - Director - > 10% Owner

2021-06-04 16:14:14 -0400 2021-06-02 A 10,000 a 10,000 direct

MAHONEY DAVID L - Director

2021-06-04 16:15:41 -0400 2021-06-02 A 10,000 a 10,000 direct

MACPHEE JOHN A - Director

2021-06-04 16:15:05 -0400 2021-06-02 A 5,000 a 202,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

PAPAPETROPOULOS SPYRIDON - Director

2021-06-04 16:16:19 -0400 2021-06-02 A 10,000 a 10,000 direct

BIGHAM MICHAEL - Director

2021-06-04 16:12:57 -0400 2021-06-02 A 5,000 a 10,000 direct -2.0 1.2 -0.6 12.2 21 -2.6 3

DIER MARDI - Director

2021-06-04 16:13:53 -0400 2021-06-02 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 22:15:03 UTC -0.5343 0.6143 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 21:45:03 UTC -0.5343 0.6143 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 21:15:03 UTC -0.5343 0.6143 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 20:45:03 UTC -0.5449 0.6249 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 20:15:05 UTC -0.5449 0.6249 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 19:45:03 UTC -0.5449 0.6249 550000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 19:15:03 UTC -0.5449 0.6249 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 18:45:03 UTC -0.5449 0.6249 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 18:15:03 UTC -0.5449 0.6249 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 17:45:03 UTC -0.5449 0.6249 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 17:15:02 UTC -0.5449 0.6249 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 16:45:02 UTC -0.5585 0.6385 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 16:15:03 UTC -0.5585 0.6385 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 15:45:02 UTC -0.5585 0.6385 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 15:15:03 UTC -0.5585 0.6385 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 14:45:03 UTC -0.5582 0.6382 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 14:15:03 UTC -0.5582 0.6382 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 13:45:03 UTC -0.5582 0.6382 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 13:15:03 UTC -0.5582 0.6382 600000
ADAMAS PHARMACEUTICALS INC ADMS 2021-07-23 12:45:03 UTC -0.5582 0.6382 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments